Intracellular signaling pathways involved in mediating the effects of lead on the transcription factor Sp1

被引:28
作者
Atkins, DS
Basha, MR
Zawia, NH [1 ]
机构
[1] Univ Rhode Isl, Dept Biomed Sci, Kingston, RI 02881 USA
[2] Meharry Med Coll, Dept Pharmacol, Nashville, TN 37028 USA
关键词
Pb; Sp1; PLK; MAPK; CNS; PC12;
D O I
10.1016/S0736-5748(03)00067-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has been well established that exposure to Pb during critical periods of brain development results in both cognitive and behavioral deficits. Although the mechanism by which Ph induces developmental neurotoxicity is unknown, it may involve alterations in transcription of genes that are essential for growth and differentiation. Recent studies reveal that Pb interferes with growth and differentiation by acting on the transcription factor Sp1. Pb-induced changes in the activity of Sp1 may be consequent to alterations in intermediates in signal transduction pathways. This study examines both in vivo and in vitro the role of signaling factors in mediating the effects of Pb on Sp1 DNA-binding. Hippocampal developmental profiles of Sp1 DNA-binding, PKC, and MAPK protein levels were monitored in Pb-exposed rats. Pb exposure resulted in an induction of SpI DNA-binding during PND 5-10 followed by a subsequent decline on PND 15-20. The protein expression profiles for PKC(x and MAPK followed a relatively similar pattern. To examine the interdependence between Sp1 DNA-binding, PKCalpha, and MAPK, PC12 cells were exposed to Pb and/or NGF. Pb or NGF exposure increased Sp1 DNA-binding. Addition of the PKC inhibitor (staurosporine) diminished NGF and Pb-induced Sp1 DNA-binding, while the MAPK inhibitor (PD 98059), completely abolished both basal and induced SpI DNA-binding. These findings demonstrate that SpI DNA-binding is regulated by PKC and MAPK, which may serve as mediators through which Pb may indirectly modulate SpI DNA-binding. (C) 2003 ISDN. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 40 条
[1]  
ADUNYAH SE, 1991, J BIOL CHEM, V266, P5670
[2]   Lead-induced developmental perturbations in hippocampal Sp1 DNA-binding are prevented by zinc supplementation: in vivo evidence for Pb and Zn competition [J].
Basha, MR ;
Wei, W ;
Brydie, M ;
Razmiafshari, M ;
Zawia, NH .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2003, 21 (01) :1-12
[3]   MECHANISMS OF LEAD NEUROTOXICITY [J].
BRESSLER, JP ;
GOLDSTEIN, GW .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (04) :479-484
[4]   PHORBOL ESTER RECEPTORS AND PROTEIN-KINASE-C IN PRIMARY NEURONAL CULTURES - DEVELOPMENT AND STIMULATION OF ENDOGENOUS PHOSPHORYLATION [J].
BURGESS, SK ;
SAHYOUN, N ;
BLANCHARD, SG ;
LEVINE, H ;
CHANG, KJ ;
CUATRECASAS, P .
JOURNAL OF CELL BIOLOGY, 1986, 102 (01) :312-319
[5]   Mammalian MAP kinase signalling cascades [J].
Chang, LF ;
Karin, M .
NATURE, 2001, 410 (6824) :37-40
[6]   Lead exposure in pheochromocytoma (PC12) cells alters neural differentiation and Sp1 DNA-binding [J].
Crumpton, T ;
Atkins, DS ;
Zawia, NH ;
Barone, S .
NEUROTOXICOLOGY, 2001, 22 (01) :49-62
[7]   Protein kinase C activation is required for the lead-induced inhibition of proliferation and differentiation of cultured oligodendroglial progenitor cells [J].
Deng, WB ;
Poretz, RD .
BRAIN RESEARCH, 2002, 929 (01) :87-95
[8]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[9]   Lead inhibition of DNA-binding mechanism of Cys2His2 zinc finger proteins [J].
Hanas, JS ;
Rodgers, JS ;
Bantle, JA ;
Cheng, YG .
MOLECULAR PHARMACOLOGY, 1999, 56 (05) :982-988
[10]   Lead-induced alterations of glial fibrillary acidic protein (GFAP) in the developing rat brain [J].
Harry, GJ ;
Schmitt, TJ ;
Gong, ZL ;
Brown, H ;
Zawia, N ;
Evans, HL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 139 (01) :84-93